Stay updated on Intranasal Ketamine in Autism Social Impairment Clinical Trial

Sign up to get notified when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intranasal Ketamine in Autism Social Impairment Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays the completed clinical-trial record for intranasal ketamine in autism, including eligibility criteria, study design, and outcome measures, instead of a 403 error.
    Difference
    46%
    Check dated 2026-11-09T12:40:38.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 rather than v3.7.2. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:12:43.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T11:38:11.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer's revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T12:23:12.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1; the 403 Forbidden page remains otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-12T14:11:24.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    A 403 Forbidden error content is displayed in place of the study record, signaling blocked access to the page. The visible structure remains, but the main content shows an error instead of the study details.
    Difference
    18%
    Check dated 2026-09-21T20:44:00.000Z thumbnail image

Stay in the know with updates to Intranasal Ketamine in Autism Social Impairment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.